150 Participants Needed

Protein Supplement for Frailty in Heart Surgery Patients

(PROTECT-CS Trial)

Recruiting at 2 trial locations
DK
RA
Overseen ByRakesh Arora, BKin,MD,PhD,
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: St. Boniface Hospital

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine whether a protein supplement can aid frail patients in recovering more effectively after heart surgery. Frail patients often struggle with longer recovery times and may lose some independence post-surgery. The trial will compare a special protein drink, ISOlution protein supplement, with a placebo (a lookalike drink with no nutritional benefit) to assess its impact on recovery. The study seeks participants aged 60 and older who are awaiting specific types of heart surgery and feel less strong or energetic than before. As an unphased trial, it offers a unique opportunity to contribute to research that may enhance recovery for future heart surgery patients.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that protein supplements can be safe and beneficial for older adults, particularly those who are frail. For example, one study found that increasing protein intake, especially with leucine-enriched whey protein, improved heart health when combined with exercise. This is significant because frailty and muscle loss are common in older patients undergoing heart surgery.

Another study found that whey protein helps maintain muscle mass and strength, which is crucial for heart patients who often experience muscle loss. These studies reported no major side effects, suggesting that the ISOlution protein supplement is well-tolerated. While these results are promising, individuals should always consult their doctor before starting any new supplement, especially if they have existing health conditions.12345

Why are researchers excited about this trial?

Researchers are excited about the ISOlution protein supplement because it takes a fresh approach to tackling frailty in heart surgery patients. Unlike current treatments that primarily focus on medications and physical rehabilitation, this supplement provides a leucine-rich protein boost, helping to boost muscle strength and recovery. By delivering essential amino acids directly through a dietary supplement, it offers a potentially quicker and more effective way to support recovery and improve outcomes for these patients. This nutritional intervention could change the game by enhancing patients' resilience and recovery speed during the critical pre- and post-surgery phases.

What evidence suggests that the ISOlution protein supplement could be effective for frailty in heart surgery patients?

This trial will compare the effects of a leucine-rich protein supplement with a placebo in frail heart surgery patients. Research has shown that protein supplements can aid frail patients in recovering better after heart surgery. Studies have found that high-protein nutrition can reduce the risk of death in very sick patients. Additionally, taking protein-rich supplements for 12 weeks has been linked to improved muscle mass and strength. This is crucial because frail patients often have weak muscles, which can slow their recovery. Although a definitive study is not yet available, these findings suggest that protein supplements might help frail heart surgery patients regain strength and recover faster.36789

Who Is on the Research Team?

RA

Rakesh Arora, BKin,MD,PhD

Principal Investigator

University of Manitoba

Are You a Good Fit for This Trial?

This trial is for patients aged 60 or older who are frail and waiting for non-emergency heart surgery. They must be able to drink by mouth, speak/read English or French, have a Clinical Frailty Score of 3-6, and an SPPB score ≤9 or SF-36 (PF) score ≤60. Excluded are those with severe cognitive impairment, kidney issues, liver cirrhosis, milk protein allergies, or very severe symptoms.

Inclusion Criteria

I am 60 or older and scheduled for specific heart surgery.
I am 60 or older and having surgery for heart valve issues or bypass.
My wait time for elective heart surgery is at least 1 week.
See 3 more

Exclusion Criteria

Significant cognitive impairment (MoCA Score < 16)
I have severe heart or lung symptoms that limit my daily activities.
I had surgery within 2 days of being admitted to the hospital.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-surgery Nutrition

Participants receive carbohydrate supplements to help with nausea symptoms, glycemic control, and GI function, and leucine-rich protein supplements for up to 2 weeks prior to surgery.

2 weeks

Post-operative Recovery

Participants receive leucine-rich protein supplements during post-operative recovery in the hospital.

6 days
In-hospital stay

Post-discharge Nutrition

Participants continue to receive leucine-rich protein supplements for 8 weeks following hospital discharge.

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 2 and 6 months post-surgery.

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • ISOlution protein supplement
  • Placebo Supplement
Trial Overview The study tests if the ISOlution protein supplement can help frail older adults recover better after heart surgery compared to a placebo. It aims to prevent muscle loss and reduce frailty by improving nutrition in these vulnerable patients before their operation.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Protein SupplementationExperimental Treatment1 Intervention
Group II: Placebo SupplementationPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Boniface Hospital

Lead Sponsor

Trials
55
Recruited
15,000+

Heart and Stroke Foundation of Canada

Collaborator

Trials
131
Recruited
72,600+

Published Research Related to This Trial

A strength training program combined with a protein-rich supplement improved the daily life status of frail elderly patients (aged 80-90) after hospitalization, indicating potential benefits for home health care.
While the impact of the protein supplement on muscle strength was unclear, the overall positive changes in daily living activities suggest that such programs could be beneficial for elderly patients transitioning from hospital to home.
[Three-case reports--a program of strength training for home health care on frail elderly patients with protein rich supplement just after the training].Iijima, S., Kurokawa, E., Masaki, K., et al.[2010]
Higher protein intake (1.0-1.2 g/kg/day) is recommended for healthy older adults to support muscle health, with benefits seen from evenly distributing protein intake across meals.
Supplementation with vitamin D (800-1000 IU) and omega-3 fatty acids (around 3 g/day) may enhance muscle mass, strength, and physical function, especially in those with low vitamin D levels.
An Update on Protein, Leucine, Omega-3 Fatty Acids, and Vitamin D in the Prevention and Treatment of Sarcopenia and Functional Decline.Tessier, AJ., Chevalier, S.[2018]
In a study of 200 community-dwelling older adults, frailty status was linked to protein intake, with frail individuals consuming less protein and branched-chain amino acids (BCAAs) compared to robust and pre-frail participants.
The relationship between frailty and protein consumption varied depending on the assessment tool used, indicating that the modified Fried's frailty phenotype (mFP) was particularly sensitive in identifying lower protein intake in frail older adults.
Protein-Related Dietary Parameters and Frailty Status in Older Community-Dwellers across Different Frailty Instruments.Coelho-Júnior, HJ., Calvani, R., Picca, A., et al.[2020]

Citations

Interventions for Frailty among Older Adults with ...There is no compelling study demonstrating a successful intervention to improve a global measure of frailty.
PROTein to Enhance outComes of (Pre)Frail paTients ...The Investigators previous study found that weight-loss and poor muscle strength (i.e. weakness) of frail patients can lead to a worse recovery ...
Evaluation of the recovery after heart surgery following ...Also, previous studies showed a decrease in the mortality rate of critically ill patients following high-protein nutritional support enriched ...
Effectiveness of Protein-enriched oral nutritional ...This study evaluated the effects of protein-enriched oral nutritional supplementation (ONS) consumption for 12 weeks on muscle mass, muscular strength, and ...
High-Protein Dietary Interventions in Heart FailureTo capture meaningful efficacy data, studies were required to report on at least one pertinent outcome. These outcomes ranged from clinical endpoints—such ...
Leucine‐enriched whey protein supplementation, resistance ...Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance‐based exercise is suggested to improve cardiometabolic health.
Interventions for Frailty Among Older Adults With ...Interventions associated with positive outcomes on frailty and physical function are multidimensional and include tailored cardiac rehabilitation.
Sarcopenia and Cardiovascular Diseases | CirculationFrailty, malnutrition, and sarcopenia are common in older patients undergoing cardiac surgery. Similar to other conditions, sarcopenia is ...
Whey protein supplementation for the preservation of mass ...This study investigates if whey protein, with exercise, can preserve muscle mass and strength in heart failure patients, as HF often causes ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security